China Starts Bioequivalence Review for Eye Drops, Patches and Sprays
China's National Medical Products Administration has launched a bioequivalence evaluation program for non-oral, non-injectable chemical drugs, initially covering eye drops, with patches and sprays to follow from July 1, 2027. The move extends the existing consistency assessment framework beyond oral solid dosage forms and injections.
China's National Medical Products Administration has announced a new bioequivalence evaluation program for chemical drug dosage forms other than oral solids and injections. The initiative will gradually expand consistency assessments to include eye drops, patches, sprays and other dosage forms.
The evaluation for eye drops begins with the publication of the notice, while assessments for patches and sprays are scheduled to start on July 1, 2027.
Why this event matters
The event has a measured impact on 3 industrys. The strongest current signal is positive for Medical Consumables, with intensity 80/100 and 90% confidence over a medium term horizon.
Medical Consumables
- Direction
- positive
- Intensity
- 80
- Confidence
- 90%
- Horizon
- Medium term
Medical Equipment
- Direction
- positive
- Intensity
- 70
- Confidence
- 85%
- Horizon
- Medium term
Pharmaceuticals
- Direction
- positive
- Intensity
- 60
- Confidence
- 80%
- Horizon
- Medium term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.